trihexyphenidyl has been researched along with Ambulation Disorders, Neurologic in 3 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, A | 1 |
| Sinha, S | 1 |
| Narang, A | 1 |
| Chouhan, DK | 1 |
| Gupta, S | 1 |
| Kuo, SH | 1 |
| Greene, P | 1 |
| Lee, WK | 1 |
| Yu, ZH | 1 |
| Lee, CC | 1 |
3 other studies available for trihexyphenidyl and Ambulation Disorders, Neurologic
| Article | Year |
|---|---|
Waddling Gait: A complication of valproate therapy and a thought beyond vitamin D deficiency.
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Drug Therapy, Combination; Epilepsy, Absence; Fem | 2020 |
Clinical reasoning: a 16-year-old boy with freezing of gait.
Topics: Adolescent; Gait Disorders, Neurologic; Humans; Male; Pantothenate Kinase-Associated Neurodegenerati | 2010 |
Delayed neurological sequelae after carbon monoxide poisoning.
Topics: Adult; Antiparkinson Agents; Brain; Brain Infarction; Carbon Monoxide Poisoning; Cognition Disorders | 2008 |